Use of inhibitors of pkc for the manufacture of a medicament...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/40 (2006.01) A61K 31/407 (2006.01)

Patent

CA 2263499

A method for treating central nervous system associated with HIV infection is disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4- [N,N'-1,1'-((2''-ethoxy)-3'''(O)-4'''-(N,N-dimethylamino)-butane)-bis-(3,3'- indolyl)]-1(H)-pyrrole-2,5-dione hydrochloride salt.

Méthode de traitement du système nerveux central associé à des infections causées par le virus de l'immunodéficience humaine (HIV), notamment au moyen de l'inhibiteur protéine kinase c (PKC) à sélectivité d'isoenzyme, sel chlorhydrate de (S)-3,4-[N,N'-1,1'-((2''-éthoxy)-3'''(0)-4'''-(N,N-diméthylamino)-butane)-bis-(3,3'-indoly1)]-(H)-pyrrole-2,5-dione.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of inhibitors of pkc for the manufacture of a medicament... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of inhibitors of pkc for the manufacture of a medicament..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of inhibitors of pkc for the manufacture of a medicament... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2042300

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.